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ABSTRACT: A new peptide sequence (MB1) has been
designed which, in the presence of a trivalent lanthanide
ion, has been programmed to self-assemble to form a three
stranded metallo-coiled coil, Ln(III)(MB1)3. The binding
site has been incorporated into the hydrophobic core using
natural amino acids, restricting water access to the
lanthanide. The resulting terbium coiled coil displays
luminescent properties consistent with a lack of ﬁrst
coordination sphere water molecules. Despite this the
gadolinium coiled coil, the ﬁrst to be reported, displays
promising magnetic resonance contrast capabilities.
Magnetic resonance imaging (MRI) is a noninvasiveimaging technique routinely employed in medical
diagnostics. Commonly paramagnetic agents, such as Gd(III)
complexes, are utilized to enhance the image contrast.1 Factors
that are important for optimal performance of these contrast
agents include the number of coordinated water molecules, the
rate at which they exchange with the bulk water, and the
tumbling rate of the complex in solution. However, the majority
of Gd(III) complexes used as MRI contrast agents do not
display optimal relaxivity, due to their small size and rapid
tumbling in solution. Eﬀorts have therefore been directed
toward the preparation of macromolecular Gd(III)-based
contrast agents. These have included modiﬁed dendrimers,
nanotubes, polymers, and liposomes, as well as natural
biological macromolecules such as proteins and chimeric
proteins.2−7 The latter are extremely attractive as they oﬀer
opportunities to incorporate biomolecular recognition, speciﬁc-
ity, and targeting into the design. Nonetheless, drawbacks are
associated with their intrinsic complexity, rendering it
challenging to correlate Gd(III) coordination chemistry with
changes to the primary amino acid sequence, and therefore
diﬃcult to redesign optimal Gd(III)−protein structures for use
in MRI.
An attractive approach would thus be to employ de novo
(from “ﬁrst principles”) peptide design in order to develop
simpliﬁed protein folds with which structure−function relation-
ships can be more readily ascertained. Though a range of
diﬀerent structural motifs have been studied, including β-sheets
and mixed α/β-motifs, the majority of work has focused on
coiled coils, in which multiple α-helices are supercoiled around
one another. Metal ion binding sites have been successfully
engineered into the interior of these structures, and one can
take advantage of various design features to alter the metal ion
coordination chemistry.8−11 This can include the hydration
state of a coordinated metal ion, a crucial parameter for
MRI.5,12−14
Of particular relevance to this work are the reports by
Hodges and co-workers on the design of a coiled coil that folds
in the presence of Ln(III) by binding to charged residues at the
α-helical interface.15,16 More recently, Kashiwada and co-
workers described the design of a Ln(III) binding site within
the hydrophobic core of a coiled coil using γ-carboxy glutamic
acid.17 However, the use of non-natural amino acids such as
these (or related derivatives) is expensive and limits their use to
peptides that are readily synthesized, making the design of
Ln(III) binding sites with natural amino-acids very attractive.
Furthermore, in both examples no details were provided
concerning the hydration state of the Ln(III) ions, and no
reports exist on Gd(III) binding. Ultimately, the opportunity to
rationally design a Gd(III) binding site for MRI applications,
has not been explored. Our eﬀorts have therefore been directed
toward designing a Gd(III) binding site within a de novo
designed α-helical coiled coil using natural amino acids and
evaluating the Gd(III) coordination chemistry, with the view to
investigating the potential of Gd(III)-coiled coils for MRI
applications.
In this study, a coiled coil structure has been designed based
on the sequence Ac-G(IaAbAcIdEeQfKg)xG-NH2, which utilizes
the heptad (a−g) repeat approach. Isoleucine (Ile, I) residues
located in the a and d positions of the heptad generate the
hydrophobic core and favor the formation of a three-stranded
coiled coil (vide infra).18 Alanine (Ala, A) residues in the b and
c positions are helix inducing, and favorable interhelical salt
bridges are formed between glutamate (Glu, E) and lysine (Lys,
K) side chains in the e and g positions.19 The Glu and Lys
residues, in addition to the glutamine (Gln, Q) residue in the f
position, help solubilize the coiled coil. A rationally designed
lanthanide binding site has been introduced in the hydrophobic
interior of the coiled coil by replacing two adjacent Ile residues
with an asparagine (Asn, N) and aspartate (Asp, D), so as to
generate a hard oxygen binding site with which to sequester, for
example, Gd(III) or Tb(III) ions that possess similar radii and
coordination preferences. A three-stranded coiled coil was
selected so that the negative charge of the Asp residues would
be neutralized on coordinating the Ln(III) ion. The Asn residue
was introduced at the d site in the second heptad (position 12),
as d sites have been reported to favor formation of three-
stranded coiled coils, whereas its introduction in an a site would
encourage the formation of a two-stranded coiled coil.18 The
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introduction of Asp in the layer directly below (position 16, a
site) completes our Ln(III) binding site, which is otherwise
ﬂanked by hydrophobic Ile layers. Finally, a tryptophan (Trp,
W) was introduced adjacent to the designed metal binding site
(in position 14, a f site) as it oﬀers a number of advantages: it
absorbs light at 280 nm (ε280 = 5690 M
−1 cm−1), allowing the
concentration of the peptide to be readily determined in
solution; its emission peak is highly sensitive to its environ-
ment; and ﬁnally, the Trp indole is capable of sensitizing
lanthanide luminescence (vide infra).
The Ln(III) binding site was modeled, and the structure was
minimized and subjected to 10.0 ns of molecular dynamics
(MD) simulations, see Figure 1. According to this model, the
Ln(III) ion is coordinated through three Asp side chains and
three carbonyl oxygen atoms from the Asn residues in the layer
above, to generate an attractive Ln(III) coordination site. These
simulations suggest that a water molecule could coordinate
directly to the Ln(III) ion. No signiﬁcant change was observed
between the energy-minimized built structure of the binding
site and the equilibrated structure, suggesting a high degree of
stability when the ion is bound.
The incorporation of Asn and Asp residues within the
hydrophobic core of the coiled coil was anticipated to be highly
destabilizing. Thus in an eﬀort to compensate for this, our
designed peptide (MB1) contains ﬁve heptad repeats (x = 5),
Ac-G IAAIEQK IAANEWK DAAIEQK IAAIEQK IAAIEQK
G-NH2, as a ﬁfth heptad has previously been reported to
stabilize a coiled coil by ∼5 kcal mol−1.20 The predicted
destabilizing eﬀect of the Ln(III) binding site, was clearly
evident in the circular dichroism (CD) spectrum of MB1 in the
absence of a metal ion. The low intensity at 222 nm (Θ222 =
−10178 deg dmol−1 cm2 res−1), which is an indication of the α-
helical content, was consistent with a poorly folded peptide
(>25%), see Figure 2A. In the absence of Ln(III) the negative
charges on the Asp residues repel each other, destabilizing the
coiled coil. However, the intensity of the minima at 222 nm
becomes more negative on addition of GdCl3 into a 30 μM
peptide monomer solution in 5 mM HEPES buﬀer pH 7.0,
reaching a plateau after addition of one Gd(III) per three-
stranded coiled coil (see Figure 2B). Under these conditions
the CD proﬁle resembled that of a well folded α-helical coiled
coil (Θ222 = −29857 deg dmol−1 cm2 res−1, ca. 76% folded)
consistent with formation of the intended Gd(MB1)3, see
Figure 2A. Mass spectrometry studies are also consistent with
the proposed Gd(III)(MB1)3 complex (see Figure S2A). The
sedimentation equilibrium data in the presence of Gd(III) were
best ﬁt to a monomer-to-trimer model (see Figure S3 and
Table S1). The CD metal titration data were therefore ﬁt to 1/3
Ln(III) + MB1 ↔ 1/3 (Ln(III)MB13), to yield an association
constant (log Ka) of 5.11 ± 0.04, see Figure 2B. This
corresponds to an estimated 86% of the total Gd(III)
complexed to the peptide, at 33 μM GdCl3 and 100 μM (3
equiv) MB1 (see Figure S4). A related titration of TbCl3 into a
solution of peptide MB1 monitored by CD yields very similar
results as for GdCl3, resulting in the formation of Tb(MB1)3
with log Ka = 5.03 ± 0.04, see Figure 2B. Similar induced
folding was observed by CD on addition of Ce(III), Nd(III),
Eu(III), Dy(III), Er(III), and Yb(III).
A thermal unfolding experiment of the apo peptide found it
to be largely unfolded over the temperature range 20−90 °C;
however, a related experiment performed in the presence of
Gd(III), displayed the beginning of a characteristic sigmoidal
unfolding curve (see Figure S5). Extrapolation of the data
indicates that the Tm is likely to be ca. 60 °C, but importantly
the Gd(MB1)3 complex remains largely folded at biologically
relevant temperatures (310 K). Combined, the CD and thermal
unfolding data indicate that the Gd(III) ion behaves like a
structural metal which is capable of inducing and stabilizing the
correct peptide fold on binding.
We studied the luminescence properties of Tb(III) in order
to obtain insight into the coordination environment around the
metal. The Trp indole located at position 14, directly adjacent
to the Tb(III) binding site, can act as a sensitizer for Tb(III)
luminescence. Microliter quantities of a solution of TbCl3 (1
mM) were added to a solution of MB1 peptide monomer (27
μM) in HEPES buﬀer pH 7.0 and the Tb(III) emission
monitored between 475 and 700 nm upon excitation at 280 nm
(Figure 3A). The characteristic sharp Tb(III) emission proﬁle
with peaks at 490, 545, 585, 620, and 650 nm is obtained, and a
plot of the integrated emission intensity over the range 530−
560 nm, as a function of Tb(III) equivalents, shows a sharp
increase followed by a plateau which is consistent with
Figure 1. (A) Structure of Gd(MB1)3 after 10.0 ns of MD simulations,
and close-up (B) side-on and (C) top-down views of the Gd(III)
coordination site. Shown are the main chain atoms represented as
helical ribbons (green), the Asn and Asp side chains in stick form
(oxygen in red and nitrogen in blue), a water molecule in ball-and-
stick form, and the Gd(III) ion as a sphere (gray).
Figure 2. (A) GdCl3 titration into 100 μM MB1 monomer in 5 mM
HEPES buﬀer pH 7.0 monitored by CD, going from 0 to 100 μM
Gd(III). (B) Plot of normalized fraction folded peptide (based on
molar ellipticity at 222 nm) as a function of Gd(III) (blue diamonds)
and Tb(III) (red triangles) equivalents per trimer. Lines represent best
ﬁts using eq 4 (Supporting Information).
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saturation of the binding site with Tb(III) ions (Figure 3B).
The saturation curve suggests that a stoichiometry of 1:3
Tb:MB1 exists in agreement with the designed Tb(MB1)3
formulation, again supported by mass spectrometry (Figure
S2B). The data can be ﬁt to yield log Ka = 4.96 ± 0.37. A
comparison of the emission intensity of Tb(MB1)3 with a
solution of TbCl3 at the same concentration shows a 30-fold
enhancement of the Tb(III) emission in the presence of MB1.
The emission enhancement is attributed to both coordination
to the binding site and sensitization by the Trp unit, as shown
by excitation spectroscopy when the Tb(III) luminescence
signal is monitored (Figure S6).
Monitoring the Trp emission signal (305−450 nm) upon
titration of TbCl3 into MB1 monomer under the same
conditions as above, shows a 30% signal increase compared
to the apo-peptide. This is accompanied by a 1 nm blue shift in
the UV−vis titration, and a 6% increase in absorption. These
results indicate that although there is sensitization from Trp to
Tb(III) an apparent decrease of Trp signal is not observed.
This is attributed to a change in the environment of the Trp
side chain upon complexation of the Tb(III) and folding of the
coiled coil.21,22
The large majority of engineered Ln(III) binding sites in
proteins are inspired by Ca(II) binding loops.23−25 Despite the
fact that our Ln(III) binding site did not evolve from a native
Ca(II) binding site, we wished to evaluate whether Ca(II)
binding would compete or interfere with the intended Ln(III)
binding. CD spectra recorded in the absence or presence of 10
mM CaCl2, were consistent with no substantial change to the
solution structure of the peptide either in the absence or
presence of Gd(III), see Figure S7. Similarly, Tb(III)
luminescence experiments performed in the presence of 10
mM CaCl2 resulted in no change to the Tb(III) emission signal
which would have decreased if Tb(III) was displaced by Ca(II),
see Figure S8. Importantly, these experiments demonstrate that
our designed peptide displays selectivity toward trivalent
lanthanide ions, consistent with the complementary charge of
our designed site and their preference for bidentate
coordination in conﬁned coordination environments.26
To obtain further information about the Tb(III) coordina-
tion environment we studied the luminescence lifetimes of
Tb(MB1)3 in H2O and D2O. The luminescence lifetime decays
of Tb(MB1)3 at 545 nm were recorded as 2.05 ms in H2O and
2.48 ms in D2O. Applying the Horrocks−Sudnick equation, 0.4
water molecules are estimated to be bound to the Tb(III) ion.27
To correct for the contribution of the outer sphere water
molecules we employed the Parker−Beeby equation, which
results in 0.1 water molecules being bound to the Tb(III) ion.28
These results infer that although there is some contribution
from outer sphere water molecules in quenching Tb(III)
luminescence, the contribution from directly coordinated water
is minimal. However, these results do not conclusively predict
the hydration state of the Gd(III) coiled coil, as it has
previously been noted that in some cases the hydration of
Gd(III) complexes behaves more like their Eu(III) analogues
than their Tb(III) analogues. To make further conclusions on
this matter, NMRD experiments are required to determine
distances between Gd(III) and water molecules.
It therefore remained for us to evaluate the MRI properties
of the resulting Gd(MB1)3 complex. The longitudinal (T1) and
transverse (T2) magnetic resonance relaxation times of water
protons were monitored in the presence of increasing
concentrations of Gd(MB1)3 and Gd(DOTA) in 10 mM
HEPES, pH 7.0, respectively, using CPMG and inversion
recovery experiments1 at 300 MHz (7 T) (Figure S9). These
experiments reveal a comparable longitudinal (r1 = 6.3 ± 2.1
mM−1 s−1) and enhanced transverse (r2 = 18.9 ± 1.5 mM
−1
s−1) relaxivity of Gd(MB1)3 compared to the widely used
contrast agent, Dotarem (GdDOTA) (r1 = 4.3 ± 1.0 mM
−1 s−1;
r2 = 5.7 ± 1.8 mM
−1 s−1). Multiple mechanisms exist whereby
the relaxation time of bulk water protons can be reduced by a
paramagnetic Gd(III). However, the luminescence decay data
are inconsistent with a mechanism which involves exchange of a
directly coordinated water molecule, as the Gd(III) is buried
within the hydrophobic core, restricting water coordination and
exchange with the bulk. Therefore the enhancement in
relaxivity is likely due to a combination of outer sphere eﬀects
and reduced tumbling. Potential outer sphere mechanisms
could involve the formation of a hydrogen bonding network
between the peptide scaﬀold and water molecules, aligning
these in close proximity to the Gd(III) for suﬃcient time for
the magnetization to be transferred to the water protons. This
is similar to a mechanism proposed for the T2 super-
paramagnetic iron oxide nanoparticles (SPIONs).29 Addition-
ally, the large number of exchangeable peptide protons in close
proximity to the Gd(III) could also be a mechanism by which
the relaxation time of bulk water protons is reduced.
T1 and T2 maps were recorded of phantom samples
containing 100 μM GdCl3 in 10 mM HEPES buﬀer pH 7.0.
On addition of MB1 and subsequent formation of Gd(MB1)3,
one observes a reduction in the T2 relaxation time, consistent
with a negative contrast agent, see Figure 4. The T1 maps show
a less pronounced change due to the lower longitudinal
Figure 3. (A) Emission spectra upon titration of Tb(III) into 26.7 μM
MB1 monomer in 5 mM HEPES buﬀer pH 7.0, ranging from 0 (dark
red) to 30 μM Tb(III) (orange), λexc = 280 nm. (B) Relative
integrated emission intensity as a function of the equivalents of
Tb(III) per trimer. Line represents best ﬁt using eq 4 (Supporting
Information).
Figure 4. T2 map of phantom samples containing 100 μM Gd(III) in
10 mM HEPES buﬀer pH 7.0. Samples a−h contain increasing
amounts of (MB1)3: 0.0 (a), 0.1 (b), 0.2 (c), 0.3 (d), 0.4 (e), 0.6 (f),
0.8 (g), and 1.0 equiv (h).
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relaxivity determined for Gd(MB1)3, see Figure S10. Our
eﬀorts are currently directed toward trying to understand the
mechanism by which our designed Gd(MB1)3 alters the
relaxation rate of bulk water.
In summary, we report the de novo design of a novel peptide
sequence which when in the presence of a trivalent lanthanide
ion and under the appropriate conditions is programmed to
yield a well folded lanthanide-coiled coil, a model of which has
been subjected to 10.0 ns of MD simulations. Both Tb(III) and
Gd(III) coiled coils were investigated, the latter representing
the ﬁrst example of its kind to be reported. The Tb(III)
complex was studied by luminescence, and the Gd(III) complex
has been shown by MRI to display promising T2 contrast agent
capabilities. Notably Ln(III) binding was achieved using natural
amino acids and was not based on a native Ca(II) binding site.
As a result the designed peptide displayed important selectivity
for Ln(III) over Ca(II). By designing the binding site within
the hydrophobic core we believe we will be able to control
water access to the paramagnetic metal ion in future designs.11
Work is currently being undertaken to enhance the Ln(III)
binding constant and to increase the number of ﬁrst
coordination sphere water molecules, so as to yield complexes
with improved relaxation eﬃciency. Importantly, this work has,
for the ﬁrst time, investigated the use of an entirely new class of
ligands for Ln(III) ions, with the view to their potential
applications as luminescent probes (Tb) and MRI contrast
agents (Gd).
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